SGRY
Surgery Partners, Inc.Company Information
- Company Name
- Surgery Partners, Inc.
- CIK
- CIK0001638833
- Category
- Large accelerated filer
- Ticker: Exchange
- SGRY: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8062
- SIC Description
- Services-General Medical & Surgical Hospitals, NEC
- Ticker
- SGRY
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-18
- Last sale
- 2026-03-16
- Shares purchased (TTM)
- 11,250
- Shares sold (TTM)
- 104,441
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 152,490,121
- Shares outstanding
- 128,825,000
- Ownership
- 118.37%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -10.60%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 217 | 182 | 240 | 203 | 250 | 229 | 270 | 222 | 214 | 185 | 196 | 236 | ||||||
| Accounts Receivable Net Current | 617 | 603 | 602 | 579 | 563 | 571 | 579 | 543 | 523 | 494 | 496 | 463 | ||||||
| Inventory Net | 99 | 101 | 97 | 92 | 87 | 88 | 88 | 82 | 81 | 77 | 75 | 69 | ||||||
| Prepaid Expense Current | 48 | 39 | 41 | 45 | 46 | 36 | 36 | 45 | 45 | 32 | 31 | 35 | ||||||
| Other Assets Current | 146 | 158 | 171 | 183 | 159 | 150 | 146 | 144 | 150 | 108 | 97 | 73 | ||||||
| Assets Current | 1,126 | 1,083 | 1,151 | 1,102 | 1,105 | 1,075 | 1,119 | 1,036 | 1,013 | 896 | 895 | 876 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 1,123 | 1,135 | 1,153 | 1,164 | 1,180 | 1,151 | 1,088 | 1,005 | 1,006 | 983 | 969 | 940 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | 41 | - | - | - | 46 | - | - | - | 55 | - | ||||||
| Goodwill | - | - | 5,195 | - | - | - | 5,068 | - | - | - | 4,326 | - | ||||||
| Intangible Assets Net Including Goodwill | 5,242 | 5,245 | - | 5,135 | 5,140 | 5,171 | - | 4,862 | 4,859 | 4,451 | - | 4,301 | ||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 227 | 225 | 234 | 229 | 220 | 219 | 215 | 215 | 227 | 189 | 184 | 196 | ||||||
| Operating Lease Right Of Use Asset | 279 | 282 | 289 | 276 | 272 | 278 | 296 | 298 | 267 | 258 | 255 | 245 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | 0 | 79 | 82 | 87 | 90 | 105 | ||||||
| Other Assets Noncurrent | 54 | 73 | 57 | 41 | 38 | 56 | 58 | 41 | 36 | 112 | 103 | 117 | ||||||
| Assets | 8,050 | 8,042 | 8,120 | 7,947 | 7,955 | 7,949 | 7,890 | 7,534 | 7,489 | 6,976 | 6,877 | 6,780 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 175 | 169 | 209 | 175 | 175 | 165 | 209 | 171 | 174 | 174 | 172 | 149 | ||||||
| Employee Related Liabilities Current | 73 | 77 | 65 | 70 | 59 | 67 | 60 | 65 | 63 | 69 | 74 | 82 | ||||||
| Other Liabilities Current | 227 | 236 | 243 | 239 | 229 | 234 | 254 | 242 | 222 | 204 | 204 | 208 | ||||||
| Long Term Debt And Capital Lease Obligations Current | 103 | 100 | 99 | 103 | 110 | 104 | 101 | 97 | 92 | 77 | 73 | 62 | ||||||
| Liabilities Current | 579 | 582 | 616 | 586 | 573 | 569 | 624 | 575 | 552 | 523 | 523 | 501 | ||||||
| Long Term Debt And Capital Lease Obligations | 3,648 | 3,614 | 3,603 | 3,461 | 3,465 | 3,447 | 3,269 | 3,094 | 3,040 | 2,794 | 2,702 | 2,640 | ||||||
| Operating Lease Liability Noncurrent | 266 | 272 | 280 | 266 | 264 | 273 | 292 | 286 | 258 | 251 | 249 | 241 | ||||||
| Deferred Income Tax Liabilities Net | 54 | 52 | 53 | 43 | 37 | 39 | 39 | - | - | - | 0 | - | ||||||
| Other Liabilities Noncurrent | 34 | 42 | 41 | 38 | 36 | 35 | 30 | 30 | 21 | 46 | 41 | 79 | ||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 367 | 383 | 396 | 411 | 422 | 431 | 439 | 436 | 442 | 324 | 327 | 332 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital | 2,544 | 2,548 | 2,541 | 2,543 | 2,538 | 2,526 | 2,521 | 2,514 | 2,511 | 2,496 | 2,498 | 2,495 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -9 | -11 | -14 | -14 | -13 | -12 | 5 | 11 | 37 | 52 | 58 | 77 | ||||||
| Retained Earnings Accumulated Deficit | -866 | -851 | -815 | -800 | -778 | -775 | -737 | -629 | -597 | -582 | -569 | -568 | ||||||
| Stockholders Equity | 3,102 | 3,098 | 3,131 | 3,142 | 3,157 | 1,740 | 1,790 | 3,112 | 1,952 | 1,967 | 1,987 | 2,005 | ||||||
| Minority Interest | 1,431 | 1,410 | 1,418 | 1,413 | 1,408 | 1,416 | 1,407 | 1,215 | 1,224 | 1,071 | 1,047 | 982 | ||||||
| Liabilities And Stockholders Equity | 8,050 | 8,042 | 8,120 | 7,947 | 7,955 | 7,949 | 7,890 | 7,534 | 7,489 | 6,976 | 6,877 | 6,780 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization | 718 | 686 | - | 620 | 589 | 587 | - | 559 | 519 | 485 | - | 426 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 131 | 131 | 129 | 129 | 128 | 128 | 127 | 127 | 127 | 127 | 127 | 126 | ||||||
| Shares Outstanding | 131 | 131 | 129 | 129 | 128 | 128 | 127 | 127 | 127 | 127 | 127 | 126 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSurgery Partners, Inc. (SGRY) — SEC Financial Statements & Analysis
Surgery Partners, Inc. (SGRY) is a services-general medical & surgical hospitals, nec company, incorporated in DE. Surgery Partners, Inc. trades on Nasdaq as: SGRY. Surgery Partners, Inc. (SGRY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Surgery Partners, Inc. carries a market cap of $2.16B, a P/E ratio of 58.18x, a P/B ratio of 0.70x, a P/S ratio of 0.64x, an enterprise value of $5.70B, and an EV/EBITDA multiple of 10.16x. On profitability, it posts a gross margin of 70.36%, an operating margin of 11.40%, a net margin of 1.11%, a Return on Equity (ROE) of 1.19%, a Return on Assets (ROA) of 0.46%, and a Return on Invested Capital (ROIC) of 5.79%. Per share, it reports EPS of $0.29, diluted EPS of $0.29, free cash flow per share of $1.46, and a dividend per share of $1.65. Over the trailing year, it posted revenue growth of 3.99% year-over-year, net income growth of -138.91% year-over-year, and EPS growth of -138.35% year-over-year. On the balance sheet, it maintains a current ratio of 1.95x, a quick ratio of 1.69x, working capital of $547.50M, a debt-to-equity ratio of 0.19x, a debt ratio of 0.07, an interest coverage ratio of 1.36x, free cash flow of $187.60M (TTM), and net debt of $3.53B. Figures sourced from SEC EDGAR.
- Market Cap
- $2.16B
- P/E TTM
- 58.18x
- EPS TTM
- $0.29
- P/B TTM
- 0.70x
- ROE TTM
- 1.19%
- ROA TTM
- 0.46%
- Debt To Equity
- 0.19x
- Free Cash Flow TTM
- $187.60M
- Net Revenue TTM Growth 1Y
- 3.99%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Surgery Partners, Inc. in?
Surgery Partners, Inc. (SGRY) operates in the Services-General Medical & Surgical Hospitals, NEC industry.
What exchange does SGRY trade on?
Surgery Partners, Inc. (SGRY) trades on the Nasdaq.
Where is Surgery Partners, Inc. incorporated?
Surgery Partners, Inc. is incorporated in DE.
When was Surgery Partners, Inc. (SGRY)'s most recent SEC filing?
Surgery Partners, Inc. (SGRY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is SGRY's market cap?
Surgery Partners, Inc. (SGRY) has a market capitalization of $2.16B as of 2026-06-30.
What is SGRY's P/E ratio?
Surgery Partners, Inc. (SGRY)'s trailing twelve month P/E ratio is 58.18x as of 2026-06-30.
What is SGRY's EPS (earnings per share)?
Surgery Partners, Inc. (SGRY)'s trailing twelve month EPS is $0.29 as of 2026-06-30.
What is SGRY's ROE (return on equity)?
Surgery Partners, Inc. (SGRY)'s trailing twelve month Return on Equity (ROE) is 1.19% as of 2026-06-30.
What is SGRY's ROA (return on assets)?
Surgery Partners, Inc. (SGRY)'s trailing twelve month Return on Assets (ROA) is 0.46% as of 2026-06-30.
What is SGRY's ROIC (return on invested capital)?
Surgery Partners, Inc. (SGRY)'s trailing twelve month Return on Invested Capital (ROIC) is 5.79% as of 2026-06-30.
What is SGRY's EV/EBITDA?
Surgery Partners, Inc. (SGRY)'s trailing twelve month EV/EBITDA is 10.16x as of 2026-06-30.